PMC:1584416 / 5142-5429 JSONTXT

{"project":"craft-sa-dev","denotations":[{"id":"T1148","span":{"begin":1,"end":2},"obj":"."},{"id":"T1149","span":{"begin":2,"end":283},"obj":"sentence"},{"id":"T1150","span":{"begin":3,"end":10},"obj":"RB"},{"id":"T1151","span":{"begin":165,"end":170},"obj":"VBZ"},{"id":"T1152","span":{"begin":10,"end":12},"obj":","},{"id":"T1153","span":{"begin":12,"end":15},"obj":"DT"},{"id":"T1154","span":{"begin":16,"end":30},"obj":"NN"},{"id":"T1155","span":{"begin":31,"end":33},"obj":"IN"},{"id":"T1156","span":{"begin":34,"end":40},"obj":"JJ"},{"id":"T1157","span":{"begin":41,"end":46},"obj":"NNS"},{"id":"T1158","span":{"begin":47,"end":49},"obj":"IN"},{"id":"T1159","span":{"begin":50,"end":52},"obj":"NN"},{"id":"T1160","span":{"begin":77,"end":85},"obj":"NNS"},{"id":"T1161","span":{"begin":53,"end":68},"obj":"NN"},{"id":"T1162","span":{"begin":69,"end":74},"obj":"NN"},{"id":"T1163","span":{"begin":75,"end":76},"obj":"NN"},{"id":"T1164","span":{"begin":86,"end":90},"obj":"IN"},{"id":"T1165","span":{"begin":91,"end":99},"obj":"JJ"},{"id":"T1166","span":{"begin":108,"end":120},"obj":"NN"},{"id":"T1167","span":{"begin":100,"end":107},"obj":"NN"},{"id":"T1168","span":{"begin":120,"end":122},"obj":","},{"id":"T1169","span":{"begin":122,"end":131},"obj":"VBG"},{"id":"T1170","span":{"begin":132,"end":140},"obj":"NNS"},{"id":"T1171","span":{"begin":141,"end":143},"obj":"IN"},{"id":"T1172","span":{"begin":144,"end":148},"obj":"CC"},{"id":"T1173","span":{"begin":149,"end":151},"obj":"NN"},{"id":"T1174","span":{"begin":152,"end":155},"obj":"CC"},{"id":"T1175","span":{"begin":156,"end":159},"obj":"NN"},{"id":"T1176","span":{"begin":160,"end":161},"obj":"-LRB-"},{"id":"T1177","span":{"begin":161,"end":162},"obj":"CD"},{"id":"T1178","span":{"begin":162,"end":163},"obj":"-RRB-"},{"id":"T1179","span":{"begin":163,"end":165},"obj":","},{"id":"T1180","span":{"begin":171,"end":176},"obj":"NN"},{"id":"T1181","span":{"begin":177,"end":179},"obj":"IN"},{"id":"T1182","span":{"begin":180,"end":183},"obj":"DT"},{"id":"T1183","span":{"begin":184,"end":191},"obj":"NN"},{"id":"T1184","span":{"begin":192,"end":194},"obj":"IN"},{"id":"T1185","span":{"begin":195,"end":199},"obj":"JJ"},{"id":"T1186","span":{"begin":214,"end":222},"obj":"NN"},{"id":"T1187","span":{"begin":200,"end":201},"obj":"DT"},{"id":"T1188","span":{"begin":202,"end":213},"obj":"JJ"},{"id":"T1189","span":{"begin":223,"end":225},"obj":"TO"},{"id":"T1190","span":{"begin":226,"end":233},"obj":"VB"},{"id":"T1191","span":{"begin":234,"end":242},"obj":"JJ"},{"id":"T1192","span":{"begin":243,"end":256},"obj":"NN"},{"id":"T1193","span":{"begin":257,"end":259},"obj":"IN"},{"id":"T1194","span":{"begin":260,"end":268},"obj":"NN"},{"id":"T1195","span":{"begin":269,"end":282},"obj":"NNS"},{"id":"T1196","span":{"begin":282,"end":283},"obj":"."}],"relations":[{"id":"R797","pred":"advmod","subj":"T1150","obj":"T1151"},{"id":"R798","pred":"punct","subj":"T1152","obj":"T1151"},{"id":"R799","pred":"det","subj":"T1153","obj":"T1154"},{"id":"R800","pred":"nsubj","subj":"T1154","obj":"T1151"},{"id":"R801","pred":"prep","subj":"T1155","obj":"T1154"},{"id":"R802","pred":"amod","subj":"T1156","obj":"T1157"},{"id":"R803","pred":"pobj","subj":"T1157","obj":"T1155"},{"id":"R804","pred":"prep","subj":"T1158","obj":"T1157"},{"id":"R805","pred":"compound","subj":"T1159","obj":"T1160"},{"id":"R806","pred":"pobj","subj":"T1160","obj":"T1158"},{"id":"R807","pred":"compound","subj":"T1161","obj":"T1160"},{"id":"R808","pred":"compound","subj":"T1162","obj":"T1163"},{"id":"R809","pred":"compound","subj":"T1163","obj":"T1160"},{"id":"R810","pred":"prep","subj":"T1164","obj":"T1160"},{"id":"R811","pred":"amod","subj":"T1165","obj":"T1166"},{"id":"R813","pred":"compound","subj":"T1167","obj":"T1166"},{"id":"R814","pred":"punct","subj":"T1168","obj":"T1166"},{"id":"R815","pred":"prep","subj":"T1169","obj":"T1166"},{"id":"R816","pred":"pobj","subj":"T1170","obj":"T1169"},{"id":"R817","pred":"prep","subj":"T1171","obj":"T1170"},{"id":"R818","pred":"preconj","subj":"T1172","obj":"T1173"},{"id":"R819","pred":"pobj","subj":"T1173","obj":"T1171"},{"id":"R820","pred":"cc","subj":"T1174","obj":"T1173"},{"id":"R821","pred":"conj","subj":"T1175","obj":"T1173"},{"id":"R822","pred":"punct","subj":"T1176","obj":"T1177"},{"id":"R823","pred":"parataxis","subj":"T1177","obj":"T1154"},{"id":"R824","pred":"punct","subj":"T1178","obj":"T1177"},{"id":"R825","pred":"punct","subj":"T1179","obj":"T1151"},{"id":"R826","pred":"dobj","subj":"T1180","obj":"T1151"},{"id":"R827","pred":"prep","subj":"T1181","obj":"T1151"},{"id":"R828","pred":"det","subj":"T1182","obj":"T1183"},{"id":"R829","pred":"pobj","subj":"T1183","obj":"T1181"},{"id":"R830","pred":"prep","subj":"T1184","obj":"T1183"},{"id":"R831","pred":"amod","subj":"T1185","obj":"T1186"},{"id":"R832","pred":"pobj","subj":"T1186","obj":"T1184"},{"id":"R833","pred":"det","subj":"T1187","obj":"T1186"},{"id":"R834","pred":"amod","subj":"T1188","obj":"T1186"},{"id":"R835","pred":"aux","subj":"T1189","obj":"T1190"},{"id":"R836","pred":"acl","subj":"T1190","obj":"T1183"},{"id":"R837","pred":"amod","subj":"T1191","obj":"T1192"},{"id":"R838","pred":"dobj","subj":"T1192","obj":"T1190"},{"id":"R839","pred":"prep","subj":"T1193","obj":"T1190"},{"id":"R840","pred":"compound","subj":"T1194","obj":"T1195"},{"id":"R841","pred":"pobj","subj":"T1195","obj":"T1193"},{"id":"R842","pred":"punct","subj":"T1196","obj":"T1151"},{"id":"R812","pred":"pobj","subj":"T1166","obj":"T1164"}],"text":"e. However, the identification in recent years of XP complementation group D patients with atypical disease presentation, including symptoms of both XP and TTD [8], casts doubt on the ability of such a monoallelic paradigm to explain clinical heterogeneity in compound heterozygotes.\nPre"}

{"project":"craft-ca-core-dev","denotations":[{"id":"T457","span":{"begin":206,"end":213},"obj":"SO:0001023"}],"text":"e. However, the identification in recent years of XP complementation group D patients with atypical disease presentation, including symptoms of both XP and TTD [8], casts doubt on the ability of such a monoallelic paradigm to explain clinical heterogeneity in compound heterozygotes.\nPre"}

{"project":"craft-ca-core-ex-dev","denotations":[{"id":"T553","span":{"begin":206,"end":213},"obj":"SO_EXT:0001023"}],"text":"e. However, the identification in recent years of XP complementation group D patients with atypical disease presentation, including symptoms of both XP and TTD [8], casts doubt on the ability of such a monoallelic paradigm to explain clinical heterogeneity in compound heterozygotes.\nPre"}

{"project":"2_test","denotations":[{"id":"17020410-11709541-84795136","span":{"begin":161,"end":162},"obj":"11709541"},{"id":"T90035","span":{"begin":161,"end":162},"obj":"11709541"}],"text":"e. However, the identification in recent years of XP complementation group D patients with atypical disease presentation, including symptoms of both XP and TTD [8], casts doubt on the ability of such a monoallelic paradigm to explain clinical heterogeneity in compound heterozygotes.\nPre"}